Back
Alnylam Pharmaceuticals Stock Price Chart
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
41
ALNY
Alnylam Pharmaceuticals
Last Price:
285.72
Seasonality Move:
13.96%
7 Day Trial
ALL ACCESS PASS
$
7
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.- The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
Alnylam Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 291.18 | Sell |
| 20-day SMA: | 282.87 | Buy |
| 50-day SMA: | 274.65 | Buy |
| 200-day SMA: | 204.43 | Buy |
| 8-day EMA: | 288.3 | Sell |
| 20-day EMA: | 284.33 | Buy |
| 50-day EMA: | 272.82 | Buy |
| 200-day EMA: | 225.29 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.22 | Buy |
| Relative Strength Index (14 RSI): | 52.21 | Buy |
| Chaikin Money Flow: | 18297 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (270.92 - 291.12) | Buy |
| Bollinger Bands (100): | (215.05 - 289.81) | Buy |
Alnylam Pharmaceuticals Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 284.69 while ALNY 8-day simple moving average is 291.18, which is a Sell signal.
- The stock price of ALNY is 284.69 while Alnylam Pharmaceuticals 20-day SMA is 282.87, which makes it a Buy.
- Alnylam Pharmaceuticals 50-day simple moving average is 274.65 while ALNY share price is 284.69, making it a Buy technically.
- ALNY stock price is 284.69 and Alnylam Pharmaceuticals 200-day simple moving average is 204.43, creating a Buy signal.
ALNY Technical Analysis vs Fundamental Analysis
Sell
41
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a Sell
The current Alnylam Pharmaceuticals [ALNY] share price is $284.69. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
36.55B
Price in USD:
284.69
Share Volume:
610.01K
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
304.39
52-Week Low:
141.98
Sell
41
Alnylam Pharmaceuticals (ALNY)
is a Sell
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?
The Alnylam Pharmaceuticals stock price is 284.69 USD today. -
Will ALNY stock go up or go down?
Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Alnylam Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 284.69 while ALNY 8-day exponential moving average is 288.30, which is a Sell signal.
- The stock price of ALNY is 284.69 while Alnylam Pharmaceuticals 20-day EMA is 284.33, which makes it a Buy.
- Alnylam Pharmaceuticals 50-day exponential moving average is 272.82 while ALNY share price is 284.69, making it a Buy technically.
- ALNY stock price is 284.69 and Alnylam Pharmaceuticals 200-day simple moving average is 225.29, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.77 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.32 per share, and an increase next year of $0.75 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
- ALNY Moving Average Covergence Divergence (MACD) indicator is 5.22, suggesting Alnylam Pharmaceuticals is a Buy
- Alnylam Pharmaceuticals Relative Strength Index (RSI) is 52.21, which suggest Alnylam Pharmaceuticals is overbought
- The Bollinger Bands (25) for Alnylam Pharmaceuticals is (270.92 - 291.12), which suggest Alnylam Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Alnylam Pharmaceuticals is (215.05 - 289.81), which suggest Alnylam Pharmaceuticals is a Buy
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.